Publisher： Bentham Science Publishers
E-ISSN： 1873-5576|18|4|328-336
ISSN： 1568-0096
Source： Current Cancer Drug Targets, Vol.18, Iss.4, 2018-04, pp. : 328-336
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. :
Access to resources
Recommend
The mu opioid receptor: A new target for cancer therapy?
Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. :
The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. :
Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy
Current Drug Targets, Vol. 4, Iss. 4, 2003-05 ,pp. :